| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |